Qifan Zhou

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Structure-Based Design and Optimization of Onradivir-Derived PB2 Inhibitors for the Treatment of Influenza A
  Journal of Medicinal Chemistry 2026 DOI: 10.1021/acs.jmedchem.6c01134
  +Save
• Dual Inhibition of PB2 and JAK2 for Influenza: A Strategy Combining Antiviral and Host-Directed Immune Modulation
  Molecules 2026 DOI: 10.3390/molecules31040696
  +Save
• Development of an Optimized Synthetic Process for Onradivir Featuring a “One-Pot” Miyaura–Suzuki Coupling Reaction
  Organic Process Research & Development 2025 DOI: 10.1021/acs.oprd.5c00175
  +Save
• Identification and Evaluation of Non-Nucleosidic MTase Inhibitors against SARS-CoV-2 nsp14 with Lower-Micromolar Anti-Coronavirus Activity
  ACS Infectious Diseases 2025 DOI: 10.1021/acsinfecdis.4c01044
  +Save
• The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants
  Science Translational Medicine 2022 DOI: 10.1126/scitranslmed.abm7621
  +Save
• tert-Butyl(3-cyano-4,6-dimethylpyridin-2-yl)carbonate as a green and chemoselective N-tert-butoxycarbonylation reagent
  New Journal of Chemistry 2019 DOI: 10.1039/C9NJ00885C
  +Save